Preferred Label : isospaglumic acid;
MeSH note : mediator in the sensitivity of animals to hyperbaric oxygenation; Naaxia is the tradename;
apparently can have both a neuroprotective and a neurotoxic effect;
CISMeF synonym : N-acetyl-aspartyl-glutamate; NAAGA sodium salt; ZY 15106; zy 15109; naaxia; N-ACETYLASPARTYLGLUTAMIC ACID;
MeSH synonym : N-acetyl-aspartyl-glutamic acid; N-acetyl-L-alpha-aspartylglutamic acid; NAAGA; N-(N-acetyl-l-alpha-aspartyl)-l-glutamic acid; N-acetyl-1-aspartylglutamic acid; N-acetyl-l-aspartyl-l-glutamate;
MeSH hyponym : NAAGA magnesium salt; Zy15109; Zy-15109; ZY15106; ZY-15106; N-acetylaspartylglutamate; N-acetyl-1-Asp-Glu;
MeSH Related Number : N-acetyl-1-aspartylglutamic acid, (L)-isomer ion; N-acetyl-1-aspartylglutamic acid, magnesium salt; 113701-65-8 (Mg salt); 15273-05-9 ((L)-isomer ion); 3106-85-2;
Registry Number MeSH : 3106-85-2;
Related CAS MeSH : 15273-05-9 (N-acetyl-1-aspartylglutamic acid, (L)-isomer ion); 113701-65-8 (N-acetyl-1-aspartylglutamic acid, magnesium salt);
related registry number list (CISMeF) : 113701-65-8 (Mg salt); 15273-05-9 ((L)-isomer ion);
CISMeF hyponym : N-acétylaspartylglutamate;
Is substance : O;
UNII : 1W8M12WXYL;
Origin ID : C027172;
UMLS CUI : C0771562;
ATC code(s)
ATC code(s)
Currated CISMeF NLP mapping
MeSH indexing information
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
Semantic type(s)
UMLS correspondences (same concept)
https://www.has-sante.fr/portail/jcms/c_2890831/fr/naabak-naaxia-naaxiafree
2018
false
true
false
France
spaglumic acid
administration, ophthalmic
insurance, health, reimbursement
treatment outcome
evaluation of the transparency committee
naaxia
isospaglumic acid
dipeptides
---
http://www.lecrat.eu/?s=Acide+N-ac%C3%A9tyl+aspartyl+glutamique
France
drug information
isospaglumic acid
pregnancy, high-risk
acetylation
isospaglumic acid
pregnancy, nos
glutamic acid
teratogens
---
http://www.has-sante.fr/portail/jcms/c_1343150/naabak-naaxia-naaxiafree
http://www.has-sante.fr/portail/upload/docs/evamed/CT-11688_NAABAK-NAAXIA-NAAXIAFREE_05122012_Avis1_CT11688_RI_PIS.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_632491
2012
France
French
isospaglumic acid
dipeptides
anti-allergic agents
other antiallergics
insurance, health, reimbursement
conjunctivitis, allergic
ophthalmic solutions
dipeptides
administration, ophthalmic
NAAGA sodium salt
evaluation of the transparency committee
Allergic blepharoconjunctivitis
---
http://www.has-sante.fr/portail/display.jsp?id=c_461153
2006
France
French
administration, intranasal
anti-allergic agents
histamine h1 antagonists
dipeptides
isospaglumic acid
insurance, health, reimbursement
rhinitis, allergic, seasonal
rhinitis, allergic, perennial
antiallergic agents, excl. corticosteroids
dipeptides
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/display.jsp?id=c_399632
2002
France
evaluation of the transparency committee
eyedrops
glutamic acid
acetylation
ophthalmic solutions
isospaglumic acid
isospaglumic acid
---